Skip to main content
Top
Published in: Journal of Cancer Survivorship 4/2015

01-12-2015

Treatment summaries, follow-up care instructions, and patient navigation: could they be combined to improve cancer survivor’s receipt of follow-up care?

Author: Jennifer M. Jabson

Published in: Journal of Cancer Survivorship | Issue 4/2015

Login to get access

Abstract

Purpose

Cancer survivors require follow-up care to ensure early detection of recurrence, management of late/long term effects, preventive screening for early detection of second primary malignancies, as well as other forms of preventive care. But not all survivors receive necessary follow-up care. Combining survivorship care plans and patient navigation may be a successful strategy to improve survivor’s receipt of necessary follow-up care.

Methods

Using data from the 2010 LIVESTRONG online survey of cancer survivors (N = 3854), this study tested associations between receipt of follow-up care instructions (FCI) and treatment summaries (TS) paired with patient navigation (PN), and survivor’s receipt of cancer surveillance, preventive cancer screening, and attendance at regular medical appointments.

Results

Survivors who received FCI, TS, and patient navigation were the most likely to report attendance at all medical appointments (aOR 4.17, 95 % CI 2.30, 7.57, p ≤ .001) and receipt of preventive cancer screening (aOR 3.56, 95 % CI 2.28, 5.55, p ≤ .001).

Conclusions

Likelihood of receiving follow-up care was greatest when survivors received FCI, TS, and PN. This pairing appeared to be most beneficial for survivor’s attendance at medical appointments and receipt of preventive cancer screening.

Implications for cancer survivors

By improving attendance at medical appointments and prevention cancer screening, pairing SCP and PN could benefit survivors through reduced recurrence, earlier recurrence detection, and prevention of second primaries.
Literature
1.
go back to reference American Cancer Society. Cancer Treatment & Survivorship. Facts & Figures 2014-2015. Atlanta: American Cancer Society; 2014. American Cancer Society. Cancer Treatment & Survivorship. Facts & Figures 2014-2015. Atlanta: American Cancer Society; 2014.
2.
go back to reference American Cancer Society. Cancer Facts & Figures 2013. Atlanta: American Cancer Society; 2013. American Cancer Society. Cancer Facts & Figures 2013. Atlanta: American Cancer Society; 2013.
3.
go back to reference Underwood JM, Townsend JS, Steweart SL, Buchannan N, Ekwueme DU, Hawkins NA, et al. Surveillance of demographic characteristics and health behaviors among adult cancer survivors—Behavioral Risk Factor Surveillance System, United States, 2009. MMWR. 2012;61(1):1–23.PubMed Underwood JM, Townsend JS, Steweart SL, Buchannan N, Ekwueme DU, Hawkins NA, et al. Surveillance of demographic characteristics and health behaviors among adult cancer survivors—Behavioral Risk Factor Surveillance System, United States, 2009. MMWR. 2012;61(1):1–23.PubMed
4.
go back to reference Snyder CF et al. Prevention, screening, and surveillance care for breast cancer survivors compared with controls: changes from 1998 to 2002. J Clin Oncol. 2009;27(7):1054–61.CrossRefPubMed Snyder CF et al. Prevention, screening, and surveillance care for breast cancer survivors compared with controls: changes from 1998 to 2002. J Clin Oncol. 2009;27(7):1054–61.CrossRefPubMed
5.
go back to reference Institute of Medicine (IOM). From cancer patient to cancer survivor: lost in transition. In: Hewitt M, Greenfield S, Stovall E, editors. The National Academies Press; 2005. Institute of Medicine (IOM). From cancer patient to cancer survivor: lost in transition. In: Hewitt M, Greenfield S, Stovall E, editors. The National Academies Press; 2005.
7.
go back to reference LIVESTRONG and The Centers for Disease Control and Prevention, National Action Plan for Cancer Survivorship: Advancing Public Health Strategies. 2004. LIVESTRONG and The Centers for Disease Control and Prevention, National Action Plan for Cancer Survivorship: Advancing Public Health Strategies. 2004.
8.
go back to reference Ganz PA, Casillas J, Hahn EE. Ensuring quality care for cancer survivors: implementing the survivorship care plan. Semin Oncol Nurs. 2008;24(3):208–17.CrossRefPubMed Ganz PA, Casillas J, Hahn EE. Ensuring quality care for cancer survivors: implementing the survivorship care plan. Semin Oncol Nurs. 2008;24(3):208–17.CrossRefPubMed
9.
go back to reference Earle CC. Long term care planning for cancer survivors: a health services research agenda. J Cancer Surviv. 2007;1(1):64–74.CrossRefPubMed Earle CC. Long term care planning for cancer survivors: a health services research agenda. J Cancer Surviv. 2007;1(1):64–74.CrossRefPubMed
10.
go back to reference Sabatino S, et al. Receipt of cancer treatment summaries and follow-up instructions among adult cancer survivors: results from a national survey. J Cancer Surviv. 2012; p. 1-12. Sabatino S, et al. Receipt of cancer treatment summaries and follow-up instructions among adult cancer survivors: results from a national survey. J Cancer Surviv. 2012; p. 1-12.
11.
go back to reference Jabson JM. Follow-up care instructions, treatment summaries, and cancer survivors’ receipt of follow-up health care and late/long term effects. Support Care Cancer. 2014. Jabson JM. Follow-up care instructions, treatment summaries, and cancer survivors’ receipt of follow-up health care and late/long term effects. Support Care Cancer. 2014.
12.
go back to reference Grunfeld E, Julian JA, Pond G, Maunsell E, Coyle D, Folkes A, et al. Evaluating survivorship care plans: results of a randomized clinical trial of patients with breast cancer. J Clin Oncol. 2011;29:1–8.CrossRef Grunfeld E, Julian JA, Pond G, Maunsell E, Coyle D, Folkes A, et al. Evaluating survivorship care plans: results of a randomized clinical trial of patients with breast cancer. J Clin Oncol. 2011;29:1–8.CrossRef
13.
go back to reference Brothers BM et al. Do survivorship care plans impact patients’ evaluations of care? A randomized evaluation with gynecologic oncology patients. Gynecol Oncol. 2013;129(3):554–8.PubMedCentralCrossRefPubMed Brothers BM et al. Do survivorship care plans impact patients’ evaluations of care? A randomized evaluation with gynecologic oncology patients. Gynecol Oncol. 2013;129(3):554–8.PubMedCentralCrossRefPubMed
14.
go back to reference Jabson JM, Bowen DJ, How do follow-up care instructions and treatment summaries relate to cancer survivors’ cancer-related pain? J Pain Symptom Manag. 2014. Jabson JM, Bowen DJ, How do follow-up care instructions and treatment summaries relate to cancer survivors’ cancer-related pain? J Pain Symptom Manag. 2014.
15.
17.
18.
go back to reference Rechis R, Reynolds KA, Beckjord EB, Nutt S, Burns RM, Schoefer JS. LIVESTRONG Report, 2010. TX: LiveSTRONG Austin; 2011. Rechis R, Reynolds KA, Beckjord EB, Nutt S, Burns RM, Schoefer JS. LIVESTRONG Report, 2010. TX: LiveSTRONG Austin; 2011.
20.
go back to reference Pinsky PF et al. Evidence of a healthy volunteer effect in the prostate, lung, colorectal, and ovarian cancer screening trial. Am J Epidemiol. 2007;165(8):874–81.CrossRefPubMed Pinsky PF et al. Evidence of a healthy volunteer effect in the prostate, lung, colorectal, and ovarian cancer screening trial. Am J Epidemiol. 2007;165(8):874–81.CrossRefPubMed
Metadata
Title
Treatment summaries, follow-up care instructions, and patient navigation: could they be combined to improve cancer survivor’s receipt of follow-up care?
Author
Jennifer M. Jabson
Publication date
01-12-2015
Publisher
Springer US
Published in
Journal of Cancer Survivorship / Issue 4/2015
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-015-0444-0

Other articles of this Issue 4/2015

Journal of Cancer Survivorship 4/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine